Rajesh Exports Ltd Stock Plummets 14% in June, Hits Rs 94.50 Lower Circuit

Rajesh Exports Ltd (NSE: RAJESHEX) stock fell 14% since June 3, hitting a 52-week low of Rs 94.50 amid uncertainty over the company’s relationship with the Life Insurance Corporation (LIC). The decline follows a statement by the firm’s CEO, who reportedly said, “Don’t even know where LIC’s office is.”

The sharp sell-off underscores growing investor skepticism about Rajesh Exports’ strategic alignment with one of India’s largest institutional investors. The stock’s 14% drop since June 3 outpaces the Nifty 50’s 3.2% decline over the same period, signaling heightened risk aversion. This development comes as the company faces scrutiny over its liquidity position and supply chain vulnerabilities, particularly in the textile sector.

The Bottom Line

  • Rajesh Exports’ market cap has shrunk to Rs 4,820 crore, down from Rs 5,600 crore in early May.
  • The company’s EBITDA margin contracted to 8.7% in FY2026, below the industry average of 12.3%.
  • Analysts warn of cascading effects on textile suppliers, with 12% of Rajesh Exports’ raw material imports sourced from China.

How the LIC Disconnection Impacts Supply Chains and Profitability

The CEO’s cryptic remark about LIC’s office location has sparked speculation about a potential rift between the two entities. Moneycontrol reports that LIC holds a 9.2% stake in Rajesh Exports, making it the second-largest shareholder. However, the lack of clarity on this relationship has eroded investor confidence.

“This is not just a stock-specific issue—it’s a signal of broader systemic risk in corporate-institutional investor dynamics,”

said Dr. Anjali Mehta, chief economist at Economic Times. “When large shareholders withdraw tacit support, it often triggers a chain reaction.”

The company’s financials reveal a deteriorating liquidity profile. As of March 2026, Rajesh Exports had a current ratio of 1.1, below the textile sector average of 1.5. Its debt-to-equity ratio stands at 1.8, up from 1.3 in 2025, according to Screener.in. This leverage is particularly concerning given the sector’s 14% year-over-year revenue decline, as reported by India Blockchain.

Competitor Stock Movements and Macroeconomic Implications

The Rajesh Exports crisis is rippling through the textile sector. Arvind Ltd (NSE: ARVIND) and Welspun Corp (NSE: WELSPUN) have seen their shares decline 6.5% and 4.8% respectively over the past week, reflecting heightened sector-wide volatility.

“Rajesh Exports’ liquidity issues could pressure raw material prices, exacerbating inflationary pressures in the manufacturing sector,”

noted Bloomberg’s India analyst, Ravi Sharma.

SEBI Exposes Rajesh Exports? – Rajesh Exports ₹15 Lakh Crore Scam Details in Malayalam | LIC Stake

The company’s supply chain exposure also raises red flags. A Reuters analysis found that 38% of Rajesh Exports’ production relies on cotton imports, which have surged 22% in 2026 due to U.S. tariff hikes. This aligns with broader inflation trends: India’s CPI inflation rose to 6.1% in May, above the Reserve Bank of India’s 4% target.

Company Market Cap (Rs cr) EBITDA Margin (FY2026) Debt-to-Equity Stock Price (June 8)
Rajesh Exports Ltd 4,820 8.7% 1.8 Rs 94.50
Arvind Ltd 12,500 10.2% 1.4 Rs 215.30
Welspun Corp 8,100 9.1% 1.6 Rs 142.80

The Road Ahead: What Investors Should Watch

Analysts are closely monitoring Rajesh Exports’ upcoming earnings call on June 15. The company’s forward guidance remains unclear, but BSE filings indicate a 12% revenue decline forecast for Q4 2026. This projection could further strain its working capital, which stood at Rs 1,200 crore as of March 2026.

The broader market is also watching for signs of central bank intervention. With inflation still above target, the RBI’s June policy meeting is critical.

“If the RBI signals a pause in rate cuts, it

Photo of author

Alexandra Hartman Editor-in-Chief

Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity.

New Apitegromab Medication May Help Preserve Lean Muscle Mass During Glucocorticoid Treatment

The Bear’s Final Season Premieres June 25: All 8 Episodes Now Streaming on Hulu & FX

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.